abrdn Life Sciences Investors
HQL
59 hedge funds and large institutions have $49.3M invested in abrdn Life Sciences Investors in 2018 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 23 increasing their positions, 17 reducing their positions, and 10 closing their positions.
35% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 17
30% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 10
4% more funds holding
Funds holding: 57 → 59 (+2)
0.45% more ownership
Funds ownership: 14.37% → 14.82% (+0.45%)
24% less capital invested
Capital invested by funds: $64.6M → $49.3M (-$15.3M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$2.43M |
| 2 |
CRC
Curi RMB Capital
Chicago,
Illinois
|
+$719K |
| 3 |
TJHA
Thomas J. Herzfeld Advisors
Miami Beach,
Florida
|
+$649K |
| 4 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
+$543K |
| 5 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$515K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$2.82M |
| 2 |
William Blair & Company
Chicago,
Illinois
|
-$1.14M |
| 3 |
Creative Planning
Overland Park,
Kansas
|
-$276K |
| 4 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$276K |
| 5 |
WS
Wedbush Securities
Los Angeles,
California
|
-$239K |
HQL Hedge Fund Activity: Q4 2018 in Review
59 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q4 2018, worth a combined $49.3M — down 24% from $64.6M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new HQL positions and 10 closed out — a net gain of 3 holders — while 23 added to existing stakes and 17 trimmed.
The largest buyer was Wolverine Asset Management, opening a new position worth an estimated $2.43M. The largest seller was Morgan Stanley, cutting an estimated $2.82M.
- 59 institutional investors held abrdn Life Sciences Investors (HQL) as of Q4 2018, up from 57 in Q3 2018.
- Funds reported $49.3M of abrdn Life Sciences Investors stock for Q4 2018, down 24% quarter-over-quarter.
- 13 funds opened new abrdn Life Sciences Investors positions in Q4 2018 and 10 closed out, a net change of +3 holders.
- The largest abrdn Life Sciences Investors buyer in Q4 2018 was Wolverine Asset Management, an estimated $2.43M added.
- The largest abrdn Life Sciences Investors seller in Q4 2018 was Morgan Stanley, an estimated $2.82M sold.
Based on aggregated 13F filings for Q4 2018.